{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Drug-induced interstitial lung disease", "Herbal medicine", "JADER", "Japanese Adverse Drug Event Report database", "Scutellariae radix"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38486172", "DateCompleted": {"Year": "2024", "Month": "03", "Day": "18"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "22"}, "Article": {"Language": ["eng"], "ELocationID": ["121", "10.1186/s12906-024-04428-y"], "ArticleDate": [{"Year": "2024", "Month": "03", "Day": "14"}], "Journal": {"ISSN": "2662-7671", "JournalIssue": {"Volume": "24", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Mar", "Day": "14"}}, "Title": "BMC complementary medicine and therapies", "ISOAbbreviation": "BMC Complement Med Ther"}, "ArticleTitle": "Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese Adverse Drug Event Report database.", "Pagination": {"StartPage": "121", "MedlinePgn": "121"}, "Abstract": {"AbstractText": ["Drug-induced interstitial lung disease (DIILD) is a severe adverse event leading to morbidity and mortality. This study evaluated the adverse event indicators of DIILD and time-to-onset profiles following the daily intake of herbal drugs (Scutellariae radix [\"ogon\" in Japanese], Bupleuri radix [\"saiko\" in Japanese], and Pinelliae tuber [\"hange\" in Japanese]) using the Japanese Adverse Drug Event Report database. DIILD was defined in accordance with the Medical Dictionary for Regulatory Activities.", "The Japanese Adverse Drug Event Report database contained 830,079 reports published between April 2004 and April 2023. The association between herbal medicines and DILLD was evaluated using the pharmacovigilance index as the reporting odds ratio (ROR), logistic regression models, propensity score-matching techniques, and Weibull shape parameters.", "The adjusted RORs using multivariate logistic regression models for Scutellariae radix (daily intake), Pinelliae tuber (daily intake), sex (male), age (\u2265\u200960\u00a0years), Scutellariae radix (daily intake)*age (\u2265\u200960\u00a0years), and Scutellariae radix (daily intake)* Pinelliae tuber (daily intake) were 1.47 (1.36\u2009-\u20091.59), 1.05 (1.01\u2009-\u20091.10), 1.45 (1.34\u2009-\u20091.57), 1.92 (1.74\u2009-\u20092.11), 3.35 (3.12\u2009-\u20093.60), and 1.49 (1.46\u2009-\u20091.53), respectively. DIILD onset profiles were evaluated using the Weibull shape parameter. A logistic plot of daily intake and onset of DIILD was drawn. ROR signals were detected in 32 of 54 herbal medicines, including Scutellariae radix, Bupleuri radix, and Pinelliae tuber. The median duration (days) (interquartile range) to DIILD onset was 36.0 (27.0-63.0) for Saikokaryukotsuboreito, 35.0 (21.0-55.0) for Saireito, and 31.0 (13.5-67.5) for Shosaikoto. The Weibull shape parameter beta (95% confidence interval) values for Saikokaryukotsuboreito, Saireito, and Shosaikoto were 1.36 (1.08-1.67), 1.36 (1.20-1.52), and 1.31 (0.98-1.68), respectively.", "DIILD demonstrated a dose-dependent to crude drugs. Clinicians should strive for the early detection of DIILD and avoid the inadvertent administration of herbal medicines."], "CopyrightInformation": "\u00a9 2024. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196, Japan."}], "LastName": "Oura", "ForeName": "Keita", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196, Japan."}], "LastName": "Tanaka", "ForeName": "Mizuki", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196, Japan."}], "LastName": "Matsumoto", "ForeName": "Kiyoka", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196, Japan."}], "LastName": "Satake", "ForeName": "Riko", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196, Japan."}], "LastName": "Inoue", "ForeName": "Misaki", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196, Japan."}], "LastName": "Yoshida", "ForeName": "Yu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196, Japan."}], "LastName": "Wakabayashi", "ForeName": "Wataru", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196, Japan."}, {"Identifier": [], "Affiliation": "Kaneichi Pharmaceutical, Company, Limited, Osaka, Japan."}], "LastName": "Hasegawa", "ForeName": "Shiori", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196, Japan."}, {"Identifier": [], "Affiliation": "Kifune Pharmacy, Gifu, Japan."}], "LastName": "Iwata", "ForeName": "Mari", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196, Japan."}, {"Identifier": [], "Affiliation": "Gifu Prefectural Government, Gifu, Japan."}], "LastName": "Suzuki", "ForeName": "Takaaki", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196, Japan."}], "LastName": "Maezawa", "ForeName": "Mika", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196, Japan."}, {"Identifier": [], "Affiliation": "Department of Pharmacy, Kyushu University Hospital, Fukuoka, Japan."}], "LastName": "Nakao", "ForeName": "Satoshi", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Information Science and Information System, China Pharmaceutical University, Nanjing, China."}], "LastName": "Liao", "ForeName": "Jun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Community Pharmacy, Gifu Pharmaceutical University, Gifu, Japan."}], "LastName": "Iguchi", "ForeName": "Kazuhiro", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Drug Informatics, Gifu Pharmaceutical University, 1-25-4, Daigaku-Nishi, Gifu, 501-1196, Japan. mnakamura@gifu-pu.ac.jp."}], "LastName": "Nakamura", "ForeName": "Mitsuhiro", "Initials": "M"}], "GrantList": [{"GrantID": "21K06646", "Agency": "Japan Society for the Promotion of Science", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Med Ther", "NlmUniqueID": "101761232", "ISSNLinking": "2662-7671"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Drug-Related Side Effects and Adverse Reactions"}, {"QualifierName": ["epidemiology"], "DescriptorName": "Japan"}, {"QualifierName": ["chemically induced", "epidemiology"], "DescriptorName": "Lung Diseases, Interstitial"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Schwaiblmair M, Behr W, Haeckel T, M\u00e4rkl B, Foerg W, Berghaus T. Drug induced interstitial lung disease. Open Respir Med J. 2012;6:63\u201374. doi: 10.2174/1874306401206010063.", "ArticleIdList": ["10.2174/1874306401206010063", "PMC3415629", "22896776"]}, {"Citation": "Ministry of Health, Labour and Welfare. The manual for handling disorders due to adverse drug reactions, interstitial lung disease. 2019. https://www.mhlw.go.jp/topics/2006/11/tp1122-1b.html. Accessed 15 Jun 2022."}, {"Citation": "Podolanczuk AJ, Wong AW, Saito S, Lasky JA, Ryerson CJ, Eickelberg O. Update in Interstitial lung disease 2020. Am J Respir Crit Care Med. 2021;203:1343\u20131352. doi: 10.1164/rccm.202103-0559UP.", "ArticleIdList": ["10.1164/rccm.202103-0559UP", "PMC8759209", "33835899"]}, {"Citation": "Matsumoto K, Nakao S, Hasegawa S, Matsui T, Shimada K, Mukai R, et al. Analysis of drug-induced interstitial lung disease using the Japanese Adverse Drug Event Report database. SAGE Open Med. 2020;8:2050312120918264. doi: 10.1177/2050312120918264.", "ArticleIdList": ["10.1177/2050312120918264", "PMC7262990", "32528682"]}, {"Citation": "Tsutani K. Kusuri ha risuku : Kampoyaku kara seiyoyaku wo miru. Jpn J Pharmacoepidemiol. 2010;15:31."}, {"Citation": "Kuchta K, Cameron S. Editorial: Kampo medicine in a modern context: ethnopharmacological perspectives. Front Pharmacol. 2022;13:971254. doi: 10.3389/fphar.2022.971254.", "ArticleIdList": ["10.3389/fphar.2022.971254", "PMC9480492", "36120328"]}, {"Citation": "Shimada Y, Fujimoto M, Nogami T, Watari H. Adverse events associated with ethical kampo formulations: analysis of the Domestic Adverse-Event Data Reports of the Ministry of Health, Labor, and Welfare in Japan. Evid Based Complement Alternat Med. 2019;2019:1643804. doi: 10.1155/2019/1643804.", "ArticleIdList": ["10.1155/2019/1643804", "PMC6500660", "31118950"]}, {"Citation": "Tsukiyama K, Tasaka Y, Nakajima M, Hino J, Nakahama C, Okimoto N, et al. A case of pneumonitis due to Sho-saiko-to. Nihon Kyobu Shikkan Gakkai Zasshi. 1989;27:1556\u20131561.", "ArticleIdList": ["2630777"]}, {"Citation": "Itoh T, Fujimoto H, Umekawa K, Rensha K, Minami K, Shoji S. A case of Sai-rei-to-induced pneumonitis. Nihon Kokyuki Gakkai Zasshi. 2006;44:833\u2013837.", "ArticleIdList": ["17144582"]}, {"Citation": "Miyagawa T, Mochizuki Y, Nakahara Y, Kawamura T, Sasaki S, Tsukamoto H, et al. A case of drug-induced pneumonitis due to Sai-rei-to. Nihon Kokyuki Gakkai Zasshi. 2009;47:47\u201351.", "ArticleIdList": ["19198236"]}, {"Citation": "Katou K, Mori K. Autoimmune hepatitis with drug-induced pneumonia due to Sho-saiko-to. Nihon Kokyuki Gakkai Zasshi. 1999;37:641\u2013646.", "ArticleIdList": ["10496105"]}, {"Citation": "Okada Y, Watanabe K, Suzuki Y, Suzuki K, Ito G, Muranushi A, et al. A case of hepatitis and intersitial pneumonitis induce by Hange-shasin-to and Sho-saiko-to. Kampo Med. 1999;50:57\u201365. doi: 10.3937/kampomed.50.57.", "ArticleIdList": ["10.3937/kampomed.50.57"]}, {"Citation": "Yamamoto T, Tsutsui N, Kazawa T, Sasagawa M, Sato Y. A case of drug-induced pneumonitis due to Ougon and Saiko involved in Sai-rei-to showing strong uptake of Ga scintigraphy. Niigata Igakkai Zasshi. 2016;130:699\u2013705."}, {"Citation": "Komiya K, Ishii H, Ohama M, Uchida M, Tsubone T, Iwashita T, et al. Sai-rei-to-induced lung injury: a case report and brief review of the literature. Intern Med. 2012;51:3421\u20133425. doi: 10.2169/internalmedicine.51.8705.", "ArticleIdList": ["10.2169/internalmedicine.51.8705", "23257532"]}, {"Citation": "Enomoto Y, Nakamura Y, Enomoto N, Fujisawa T, Inui N, Suda T. Japanese herbal medicine-induced pneumonitis: a review of 73 patients. Respir Investig. 2017;55:138\u2013144. doi: 10.1016/j.resinv.2016.11.007.", "ArticleIdList": ["10.1016/j.resinv.2016.11.007", "28274529"]}, {"Citation": "Ministry of Health, Labour and Welfare. Pharmaceutical and Food Safety Bureau. Pharmaceuticals and Medical Devices Safety Information No. 146. 1998. https://www.pmda.go.jp/safety/info-services/drugs/calling-attention/safety-info/0147.html. Accessed 18 May 2022."}, {"Citation": "Ministry of Health, Labour and Welfare. Pharmaceutical and Food Safety Bureau. Pharmaceuticals and Medical Devices Safety Information No. 158. 2000. https://www.pmda.go.jp/safety/info-services/drugs/calling-attention/safety-info/0089.html. Accessed 18 May 2022."}, {"Citation": "PMDA website. https://www.pmda.go.jp/safety/info-services/drugs/adr-info/suspected-adr/0004.html. 2004. Accessed 18 May 2022."}, {"Citation": "Pharmaceuticals and Medical Devices Agency. Find Review reports, PI; 2022. https://www.pmda.go.jp/english/search_index.html. Accessed 15 Jun 2022."}, {"Citation": "Japanese Maintenance Organization. Medical Dictionary for Regulatory Activities MedDRA, version 23.0; 2021. https://www.jmo.pmrj.jp. Accessed 15 Jun 2022."}, {"Citation": "The international council for harmonisation of technical requirements for pharmaceuticals for human use (ICH), Introductory guide MedDRA Version 23.0. https://admin.meddra.org/sites/default/files/guidance/file/intguide_%2024_0_English.pdf Accessed 28 Feb. 2024."}, {"Citation": "van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002;11:3\u201310. doi: 10.1002/pds.668.", "ArticleIdList": ["10.1002/pds.668", "11998548"]}, {"Citation": "Poluzzi E, Raschi E, Piccinni C, De Ponti F, Karahoca A. Data Mining Techniques in Pharmacovigilance: analysis of the publicly accessible FDA Adverse Event Reporting System (AERS). InTech. 2012. p.265\u2013302. 10.5772/50095."}, {"Citation": "Nakao S, Hasegawa S, Shimada K, Mukai R, Tanaka M, Matsumoto K, et al. Evaluation of anti-infective-related clostridium difficile-associated colitis using the Japanese Adverse Drug Event Report database. Int J Med Sci. 2020;17:921\u2013930. doi: 10.7150/ijms.43789.", "ArticleIdList": ["10.7150/ijms.43789", "PMC7163355", "32308545"]}, {"Citation": "Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41\u201355. doi: 10.1093/biomet/70.1.41.", "ArticleIdList": ["10.1093/biomet/70.1.41"]}, {"Citation": "Akimoto H, Oshima S, Negishi A, Ohara K, Ohshima S, Inoue N, et al. Assessment of the risk of suicide-related events induced by concomitant use of antidepressants in cases of smoking cessation treatment with varenicline and assessment of latent risk by the use of varenicline. PLoS One. 2016;11:e0163583. doi: 10.1371/journal.pone.0163583.", "ArticleIdList": ["10.1371/journal.pone.0163583", "PMC5033404", "27657721"]}, {"Citation": "Nakao S, Hasegawa S, Umetsu R, Shimada K, Mukai R, Tanaka M, et al. Pharmacovigilance study of anti-infective-related acute kidney injury using the Japanese Adverse Drug Event Report database. BMC Pharmacol Toxicol. 2021;22:47. doi: 10.1186/s40360-021-00513-x.", "ArticleIdList": ["10.1186/s40360-021-00513-x", "PMC8404262", "34462002"]}, {"Citation": "Sauzet O, Carvajal A, Escudero A, Molokhia M, Cornelius VR. Illustration of the Weibull shape parameter signal detection tool using electronic healthcare record data. Drug Saf. 2013;36:995\u20131006. doi: 10.1007/s40264-013-0061-7.", "ArticleIdList": ["10.1007/s40264-013-0061-7", "23673816"]}, {"Citation": "Sasaoka S, Matsui T, Hane Y, Abe J, Ueda N, Motooka Y, et al. Time-to-onset analysis of drug-induced long QT syndrome based on a spontaneous reporting system for adverse drug events. PLoS One. 2016;11:e0164309. doi: 10.1371/journal.pone.0164309.", "ArticleIdList": ["10.1371/journal.pone.0164309", "PMC5056697", "27723808"]}, {"Citation": "Nakao S, Hatahira H, Sasaoka S, Hasegawa S, Motooka Y, Ueda N, et al. Evaluation of Drug-Induced Photosensitivity Using the Japanese Adverse Drug Event Report (JADER) Database. Biol Pharm Bull. 2017;40:2158\u20132165. doi: 10.1248/bpb.b17-00561.", "ArticleIdList": ["10.1248/bpb.b17-00561", "29199239"]}, {"Citation": "van Puijenbroek EP, Egberts AC, Meyboom RH, Leufkens HG. Signalling possible drug\u2013drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole. Br J Clin Pharmacol. 1999;47:689\u2013693. doi: 10.1046/j.1365-2125.1999.00957.x.", "ArticleIdList": ["10.1046/j.1365-2125.1999.00957.x", "PMC2014250", "10383548"]}, {"Citation": "van Puijenbroek EP, Egberts AC, Heerdink ER, Leufkens HG. Detecting drug\u2013drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol. 2000;56:733\u2013738. doi: 10.1007/s002280000215.", "ArticleIdList": ["10.1007/s002280000215", "11214785"]}, {"Citation": "Qian Y, Ye X, Du W, Ren J, Sun Y, Wang H, et al. A computerized system for detecting signals due to drug\u2013drug interactions in spontaneous reporting systems. Br J Clin Pharmacol. 2010;69:67\u201373. doi: 10.1111/j.1365-2125.2009.03557.x.", "ArticleIdList": ["10.1111/j.1365-2125.2009.03557.x", "PMC2830599", "20078614"]}, {"Citation": "Montesi SB, Fisher JH, Martinez FJ, Selman M, Pardo A, Johannson KA. Update in Interstitial Lung Disease 2019. Am J Respir Crit Care Med. 2020;202:500\u2013507. doi: 10.1164/rccm.202002-0360UP.", "ArticleIdList": ["10.1164/rccm.202002-0360UP", "PMC7427378", "32412784"]}, {"Citation": "Cho SJ, Stout-Delgado HW. Aging and Lung Disease. Annu Rev Physiol. 2020;82:433\u2013459. doi: 10.1146/annurev-physiol-021119-034610.", "ArticleIdList": ["10.1146/annurev-physiol-021119-034610", "PMC7998901", "31730381"]}, {"Citation": "Selman M, Pardo A. Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. An integral model. Am J Respir Crit Care Med. 2014;189:1161\u201372. doi: 10.1164/rccm.201312-2221PP.", "ArticleIdList": ["10.1164/rccm.201312-2221PP", "24641682"]}, {"Citation": "Katayama K, Yoshino T, Munakata K, Yamaguchi R, Imoto S, Miyano S, et al. Prescription of kampo drugs in the Japanese health care insurance program. Evid Based Complement Alternat Med. 2013;2013:576973. doi: 10.1155/2013/576973.", "ArticleIdList": ["10.1155/2013/576973", "PMC3914391", "24550992"]}, {"Citation": "Matsuno O. Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches. Respir Res. 2012;13:39. doi: 10.1186/1465-9921-13-39.", "ArticleIdList": ["10.1186/1465-9921-13-39", "PMC3426467", "22651223"]}, {"Citation": "Liu ZL, Tanaka S, Horigome H, Hirano T, Oka K. Induction of apoptosis in human lung fibroblasts and peripheral lymphocytes in vitro by Sho-saiko-to derived phenolic metabolites. Biol Pharm Bull. 2002;25:37\u201341. doi: 10.1248/bpb.25.37.", "ArticleIdList": ["10.1248/bpb.25.37", "11824553"]}, {"Citation": "Barkauskas CE, Cronce MJ, Rackley CR, Bowie EJ, Keene DR, Stripp BR, et al. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest. 2013;123:3025\u20133036. doi: 10.1172/JCI68782.", "ArticleIdList": ["10.1172/JCI68782", "PMC3696553", "23921127"]}, {"Citation": "Adamson IY, Hedgecock C, Bowden DH. Epithelial cell-fibroblast interactions in lung injury and repair. Am J Pathol. 1990;137:385\u2013392.", "ArticleIdList": ["PMC1877605", "1696785"]}, {"Citation": "Antoniou KM, Margaritopoulos GA, Tomassetti S, Bonella F, Costabel U, Poletti V. Interstitial lung disease. Eur Respir Rev. 2014;23:40\u201354. doi: 10.1183/09059180.00009113.", "ArticleIdList": ["10.1183/09059180.00009113", "PMC9487254", "24591661"]}, {"Citation": "Burgoyne RA, Fisher AJ, Borthwick LA. The role of epithelial damage in the pulmonary immune response. Cells. 2021;10:2763. doi: 10.3390/cells10102763.", "ArticleIdList": ["10.3390/cells10102763", "PMC8534416", "34685744"]}, {"Citation": "Cai Y, Ma W, Xiao Y, Wu B, Li X, Liu F, et al. High doses of baicalin induces kidney injury and fibrosis through regulating TGF-\u03b2/Smad signaling pathway. Toxicol Appl Pharmacol. 2017;333:1\u20139. doi: 10.1016/j.taap.2017.08.003.", "ArticleIdList": ["10.1016/j.taap.2017.08.003", "28803990"]}, {"Citation": "Shii T, Kuroda M, Shamoto N, Mimaki Y. An analysis of the ingredients in decoctions and extracts of Kampo medicines: amounts of baicalin and baicalein in Kampo medicines containing Scutellariae radix. Nihon Ronen Igakkai Zasshi. 2020;57:72\u201380. doi: 10.3143/geriatrics.57.72.", "ArticleIdList": ["10.3143/geriatrics.57.72", "32074563"]}, {"Citation": "Li X, Li X, Huang N, Liu R, Sun R. A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins. Phytomedicine. 2018;50:73\u201387. doi: 10.1016/j.phymed.2018.09.174.", "ArticleIdList": ["10.1016/j.phymed.2018.09.174", "PMC7126585", "30466994"]}, {"Citation": "Wang Q, Zheng XL, Yang L, Shi F, Gao LB, Zhong YJ, et al. Reactive oxygen species-mediated apoptosis contributes to chemosensitization effect of saikosaponins on cisplatin-induced cytotoxicity in cancer cells. J Exp Clin Cancer Res. 2010;29:159. doi: 10.1186/1756-9966-29-159.", "ArticleIdList": ["10.1186/1756-9966-29-159", "PMC3006358", "21143894"]}, {"Citation": "Huang W, Sun R, Zhang Z. \"Dose-time-toxicity\" relationship study on hepatotoxicity caused by multiple dose of total Bupleurum saponin crude extracts to rats. Zhongguo Zhong Yao Za Zhi. 2010;35:3344\u20133347.", "ArticleIdList": ["21438404"]}, {"Citation": "Zhang X, Cai Y, Wang L, Liu H, Wang X. Optimization of processing technology of Rhizoma Pinelliae Praeparatum and its anti-tumor effect. Afr Health Sci. 2015;15:101\u2013106. doi: 10.4314/ahs.v15i1.14.", "ArticleIdList": ["10.4314/ahs.v15i1.14", "PMC4370151", "25834537"]}, {"Citation": "Zhao X, Zhao J, Hu R, Yao Q, Zhang G, Shen H, et al. Ruanjian Sanjie decoction exhibits antitumor activity by inducing cell apoptosis in breast cancer. Oncol Lett. 2017;13:3071\u20133079. doi: 10.3892/ol.2017.5832.", "ArticleIdList": ["10.3892/ol.2017.5832", "PMC5431657", "28529560"]}, {"Citation": "Zhang ZH, Zhao YY, Cheng XL, Dai Z, Zhou C, Bai X, et al. General toxicity of Pinellia ternata (Thunb.) Berit. in rat: a metabonomic method for profiling of serum metabolic changes. J Ethnopharmacol. 2013;149:303\u201310. doi: 10.1016/j.jep.2013.06.039.", "ArticleIdList": ["10.1016/j.jep.2013.06.039", "23831079"]}, {"Citation": "Montastruc JL, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol. 2011;72:905\u2013908. doi: 10.1111/j.1365-2125.2011.04037.x.", "ArticleIdList": ["10.1111/j.1365-2125.2011.04037.x", "PMC3244636", "21658092"]}, {"Citation": "Komada F, Nakayama Y, Takara K. Analysis of time-to-onset and onset-pattern of interstitial lung disease after the administration of monoclonal antibody agents. Yakugaku Zasshi. 2018;138:1587\u20131594. doi: 10.1248/yakushi.18-00094.", "ArticleIdList": ["10.1248/yakushi.18-00094", "30504674"]}, {"Citation": "Komada F. Analysis of time-to-onset of interstitial lung disease after the administration of small molecule molecularly-targeted drugs. Yakugaku Zasshi. 2018;138:229\u2013235. doi: 10.1248/yakushi.17-00194.", "ArticleIdList": ["10.1248/yakushi.17-00194", "29386436"]}, {"Citation": "Yonemori K, Hirakawa A, Kawachi A, Kinoshita F, Okuma H, Nishikawa T, et al. Drug induced interstitial lung disease in oncology phase I trials. Cancer Sci. 2016;107:1830\u20131836. doi: 10.1111/cas.13087.", "ArticleIdList": ["10.1111/cas.13087", "PMC5198943", "27685762"]}, {"Citation": "Ministry of Health, Labour and Welfare. National Health and Nutrition Surve; 2019. https://www.mhlw.go.jp/bunya/kenkou/kenkou_eiyou_chousa.html. Accessed 15 Jun 2022."}, {"Citation": "Fujita T, Nagakawa H, Izawa T, Okada T, Tanabe N, Takiguchi Y, et al. Case of Shakuyaku-kanzo-to-induced CD4 dominant pneumonitis diagnosed on day eight of the challenge test. Nihon Kokyuki Gakkai Zasshi. 2008;46:717\u2013721.", "ArticleIdList": ["18939414"]}]}], "History": [{"Year": "2023", "Month": "8", "Day": "3"}, {"Year": "2024", "Month": "3", "Day": "6"}, {"Year": "2024", "Month": "3", "Day": "18", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "3", "Day": "15", "Hour": "6", "Minute": "44"}, {"Year": "2024", "Month": "3", "Day": "15", "Hour": "0", "Minute": "45"}, {"Year": "2024", "Month": "3", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["38486172", "PMC10938654", "10.1186/s12906-024-04428-y", "10.1186/s12906-024-04428-y"]}}]}